Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA) (MELISSA)

This study has been completed.
Information provided by (Responsible Party):
Robert P. Frantz, Mayo Clinic Identifier:
First received: January 7, 2010
Last updated: February 3, 2012
Last verified: February 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2011
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)